This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cytori Announces Presentation At Biotech Showcase™ On January 13

Cytori Therapeutics, Inc. (NASDAQ:CYTX) will webcast their corporate presentation at the Biotech Showcase at 11:00 AM PT (2:00 PM ET) on Monday, January 13. The presentation will be held in the Mission II room of the Parc 55 Wyndham Hotel in San Francisco.

The presentation webcast may be accessed on the "Webcasts" page of the Investor Relations section of the Company's website. The webcast can be accessed live and will be available for replay approximately one hour after the presentation on the Company's website.

In addition, Cytori’s CEO Chris Calhoun will be participating in a panel at the Alliance for Regenerative Medicine’s (ARM) State of the Industry Briefing. The panel discussion will be filmed and will be made available at a later date on the ARM website. The details are as follows:

Biotech Showcase™ 2014: ARM’s Regenerative Medicine State of the Industry Briefing

Panel:                 Recent Financings in the Sector
Date: January 13, 2014
Time: 9:00 – 9:45 AM PT
Location: Parc 55 Wyndham, 55 Cyril Magnin Street, San Francisco, CA
Cyril Magnin Ballroom - 4th Floor
 

About Cytori

Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple “ischemic” conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori’s proprietary technologies and products, including the Celution System product family. www.cytori.com

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs